Haemonetics CorporationHAE
ASignal's systematic analysis rates HAE as Neutral.
Reflects the latest available analysis · analyzed Aug 19, 2026
The case on HAE
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Gross margin of 59.33% indicates strong pricing power
- Current ratio of 3.08x suggests solid short-term financial health
- Free cash flow of $312.84M is positive and substantial
- Forward P/E of 18.89x is reasonable relative to growth
- RSI at 83.31 indicates severely overbought conditions
- Current price trading above upper Bollinger Band (102.68), suggesting potential pullback
- High debt-to-equity ratio of 1.40x raises leverage concerns
- Trailing P/E of 52.37x is elevated relative to earnings growth
See the full verdict on HAE
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes HAE
Most investors never get a second opinion, let alone several. ASignal runs HAE past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.